September 20, 2014 11:12 AM ET

Pharmaceuticals

Company Overview of N30 Pharmaceuticals, Inc.

Key Executives for N30 Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Charles H. Scoggin M.D.10 RelationshipsChief Executive Officer and Director69
Tom Sokolowski No RelationshipsChief Financial Officer and Vice President of Finance & Administration--
Janice Troha No RelationshipsExecutive Vice President of Product Development & Regulatory--
Sherif Gabriel Ph.D.No RelationshipsVice President of Research--

N30 Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arnold Snider 94 RelationshipsN30 Pharmaceuticals, Inc.--
Charles H. Scoggin M.D. 10 RelationshipsN30 Pharmaceuticals, Inc.69
Joseph Loscalzo M.D., Ph.D. 105 RelationshipsNitroMed, Inc.62
Augustine Choi 10 RelationshipsN30 Pharmaceuticals, Inc.--
Joseph A. Vita M.D. 10 RelationshipsN30 Pharmaceuticals, Inc.--
View All Board Members

N30 Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Joseph Loscalzo105 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
420.4K
Bonus
546.8K
Total Short Term Compensation
617.8K
Total Value of Options
17.7M
Compensation as of Fiscal Year
N30 Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

The Clorox Company Announces Management Changes
September 18, 2014 8:33 PM ET
Tully M. Friedman Resigns from Board of Directors of The Clorox Company, Effective November 19, 2014
September 17, 2014 12:30 PM ET
Colgate-Palmolive Company Announces Resignation of Nikesh Arora as Director
September 11, 2014 6:07 PM ET
Suominen Corporation Announces Appointments to its Nomination Board
September 02, 2014 6:30 AM ET
Energizer Holdings Inc. Announces Executive Leadership for Household Products and Personal Care Businesses
August 29, 2014 6:15 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N30 Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.